Three big Congressional hearings next week to set the tenor on Covid-19, drug prices, and ARPA-H

Two Senate committees and a House subcommittee will hold hearings next week taking on Covid-19, future pandemics, the need to lower drug prices in Medicare, and a new health research investor to be known as ARPA-H.

The committees will all seek to advance key priorities as drug pricing legislation that included Medicare negotiations stalled, and then flat-lined when Sen. Joe Manchin dropped his support for a wider bill.